Heart Disease & Stroke Prevention Program and Diabetes Prevention – State and Local Public Health Actions to Prevent Obesity, Diabetes, and Heart Disease and Stroke
Active
- Assistance listing
- 93.813
- Agency
-
Centers for Disease Control and Prevention
Department of Health and Human Services
- Grant awards
- Not on record
Program facts
- Also known as
- State and Local Public Health Actions to Prevent Obesity, Diabetes, Heart Disease and Stroke
- Eligible applicants
-
- State (includes District of Columbia, public institutions of higher education and hospitals)
- Beneficiaries
-
- Anyone/general public
- State
- Treasury account
-
- 75-0948-0-1-550
- More information
Program details come from SAM.gov Assistance Listings. Updated .
About this program
The Centers for Disease Control and Prevention under the Department of Health and Human Services funds population-wide and priority-population approaches to prevent obesity, diabetes, and heart disease and stroke through the Heart Disease & Stroke Prevention Program and Diabetes Prevention – State and Local Public Health Actions to Prevent Obesity, Diabetes, and Heart Disease and Stroke, CFDA 93.813.
The program supports state and local public health action addressing health disparities in obesity, diabetes, and cardiovascular disease among adults. Funded activities include implementation of evidence-based prevention strategies, population health surveillance, workforce development in prevention practice, and capacity building within state and local health departments to scale prevention programming across jurisdictions. Projects operate on four-year cycles with 12-month budget periods; continuation funding beyond the initial award is available pending programmatic progress and funding availability.
Eligible applicants are state departments of health (including the District of Columbia), large city health departments serving populations of at least 900,000, and their bona fide agents. Large city applicants must partner with and obtain written support from their state health department.
The source does not report recent grant award activity, award magnitudes, funding concentration among agencies, or currently open grant opportunities. The program description indicates that the CDC Procurement and Grants Office manages awards and that applicants should contact CDC for technical assistance at (770) 488-2710 prior to submitting applications. Award notifications are issued electronically, and grantees submit annual progress reports through Grants.gov. Records must be retained for a minimum of three years after each budget period concludes, or longer if audits are pending.
Objective and description
- Objective
The purpose of this program is to support implementation of population-wide and priority population approaches to prevent obesity, diabetes, and heart disease and stroke and reduce health disparities in these areas among adults.
Eligibility
- Applicant eligibility
Eligible Applicants: State Departments of Health or their Bona Fide Agents (includes the District of Columbia) 2. Large city health departments or their bona fide agents, with populations of at least 900,000 (using July 2012 U.S. census Estimates xviii) 3.Special Eligibility Requirements: Large city applicants must work in partnership with and provide a letter of support from the state department of health or its bona fide agent documenting activities proposed.
- Beneficiary eligibility
States and communities will benefit from this assistance in many ways including through improved clinical and other preventive services for self-management of hypertension, diabetes, overweight and obesity
- Credentials and documentation
Applicants should document the need for assistance, State the objectives of the project, outline the method of operation, describe evaluation procedures, and provide a budget with justification for funds requested. Costs will be determined in accordance with 2 CFR Part 225, 45 CFR Part 92, OMB Circular No. A-102, and OMB Circular A-133.
- Uses of assistance
Continue to build on public health activities such as partnership engagement, workforce development, guidance and support for programmatic efforts, strategic communication, surveillance and epidemiology, and evaluation. Continue to extend the activities supported with basic funding under DP13-1305 under enhanced component to achieve even greater reach and impact through implementation of evidence-based strategies that are more extensive and wider-reaching than those implemented in the basic component. Supplemental funding may be provided that is specific to a chronic disease such as diabetes and/or heart disease and/or risk factor(s). Funds may be used for costs associated with planning, implementing, and evaluating chronic disease prevention and control programs
- Length and time phasing of assistance
12-month budget period within a 5-year project period
How to apply
- Application procedure
Submit Annual Progress Reports through www.Grants.gov. If you encounter any difficulties submitting your interim progress report through www.Grants.gov, please contact CDC's Technical Information Management Section at (770) 488-2700 prior to the submission deadline. If further information is needed regarding the application process, please contact the CDC Procurement and Grants Office at (770) 488-2710 located at 2920 Brandywine Road, Atlanta, GA 30341
- Criteria for selecting proposals
Continuation applications will undergo a technical review prior to award. A summary statement will be provided which may or may not require a grantee response. For any supplemental funding all applications will be reviewed initially for completeness by CDC PGO staff and will be reviewed jointly for eligibility by the CDC NCCDPHP and PGO. Incomplete applications and applications that do not meet the eligibility criteria will not advance to Phase II review. Applicants will be notified that their applications did not meet eligibility or published submission requirements. A review panel will evaluate complete, eligible applications in accordance with the "Criteria" section of the FOA. There may or may not be an additional review which will be provided in the FOA. Not more than thirty days after the Phase II review is completed, applicants will be notified electronically if their application does not meet eligibility or published submission requirements.
- Award procedure
After review and approval, a notice of award is prepared and processed, along with appropriate notification to the public, initial award provides funds for first budget period (usually 12 months) and Notice of Award indicates support recommended for the remainder of project period, allocation of Federal funds by budget categories, and special conditions, if any. However, applicants are encouraged to call CDC for programmatic technical assistance prior to the development and submission of their assistance application.
- Renewals
Renewals will be based upon the availability of funding and satisfactory programmatic progress. Project period is for 4 years with 12 month budget periods
Quick answers
What is Assistance Listing 93.813?
Assistance Listing 93.813 is Heart Disease & Stroke Prevention Program and Diabetes Prevention – State and Local Public Health Actions to Prevent Obesity, Diabetes, and Heart Disease and Stroke, a federal grant program run by Centers for Disease Control and Prevention (Department of Health and Human Services).
What is the CFDA number for Heart Disease & Stroke Prevention Program and Diabetes Prevention – State and Local Public Health Actions to Prevent Obesity, Diabetes, and Heart Disease and Stroke?
Its CFDA number is 93.813: Assistance Listing numbers were called CFDA numbers before 2018.
On GovTribe
See this program's full record
- Every grant award and opportunity under it
- Funding by recipient, agency and assistance type
- Alerts for new opportunities
- Ask GovTribe AI about this program